EUROAPI closes the financing of its FOCUS-27 plan
15 Ottobre 2024 - 5:45PM
UK Regulatory
EUROAPI closes the financing of its FOCUS-27 plan
Paris - 15 October 2024 -
EUROAPI today announces the closing of the refinanced Credit
Revolving Facility (RCF) and the Perpetual Deeply Subordinated
Hybrid Bond subscribed by Sanofi, thus completing the financing of
its FOCUS-27 strategic plan.
About EUROAPI
EUROAPI is focused on reinventing active ingredient solutions to
sustainably meet customers’ and patients’ needs around the world.
We are a leading player in active pharmaceutical ingredients with
approximately 200 products in our portfolio, offering a large span
of technologies while developing innovative molecules through our
Contract Development and Manufacturing Organization (CDMO)
activities. Taking action for health by enabling access to
essential therapies inspires our 3,650 people every day. With
strong research and development capabilities and six manufacturing
sites, all located in Europe, EUROAPI ensures API manufacturing of
the highest quality to supply customers in more than 80 countries.
EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker:
EAPI). Find out more at www.euroapi.com and follow us on
LinkedIn.
Media Relations contact:
Laurence Bollack
Tel.: +33 (0)6 81 86 80 19
mr@euroapi.com
|
Investor Relations contacts:
Sophie Palliez-Capian
Tel.: +33 (0)6 87 89 33 51
Sophie.palliez@euroapi.com
Camille Ricotier
Tel: +33 (0)6 43 29 93 79
Camille.ricotier@euroapi.com |
Forward-Looking
Statements
Certain information contained in this press release is forward
looking and not historical data. These forward-looking statements
are based on opinions, projections and current assumptions
including, but not limited to, assumptions concerning the Group’s
current and future strategy, financial and non-financial future
results and the environment in which the Group operates, as well as
events, operations, future services or product development and
potential. Forward-looking statements are generally identified by
the words “expects”, “anticipates”, “believes”, “intends”,
“estimates”, “plans” and similar expressions. Forward looking
statements and information do not constitute guarantees of future
performances, and are subject to known or unknown risks,
uncertainties and other factors, a large number of which are
difficult to predict and generally outside the control of the
Group, which could cause actual results, performances or
achievements, or the results of the sector or other events, to
differ materially from those described or suggested by these
forward-looking statements. These risks and uncertainties include
those that are indicated and detailed in Chapter 3 “Risk factors”
of the Universal Registration Document filed with the French
Financial Markets Authority (Autorité des marchés financiers, AMF)
on April 5, 2024. These forward-looking statements are given only
as of the date of this press release and the Group expressly
declines any obligation or commitment to publish updates or
corrections of the forward-looking statements included in this
press release in order to reflect any change affecting the
forecasts or events, conditions or circumstances on which these
forward-looking statements are based.
- EUROAPI_Press release_October 15, 2024
Grafico Azioni Euroapi (EU:EAPI)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Euroapi (EU:EAPI)
Storico
Da Dic 2023 a Dic 2024